BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7950581)

  • 1. Kleihauer testing. Need not be abandoned.
    Love EM; Shwe KH
    BMJ; 1994 Sep; 309(6957):805. PubMed ID: 7950581
    [No Abstract]   [Full Text] [Related]  

  • 2. Kleihauer testing. Quality assurance scheme exists.
    Urbaniak SJ; Main R; Fraser N
    BMJ; 1994 Sep; 309(6957):805. PubMed ID: 7950582
    [No Abstract]   [Full Text] [Related]  

  • 3. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of Rh immune globulin: a review.
    Sutton GP; Jay A; Lim YS; Noland JE; Boral LI
    Indiana Med; 1988 Apr; 81(4):321-2. PubMed ID: 2834434
    [No Abstract]   [Full Text] [Related]  

  • 5. Kleihauer testing. Many cases of sensitisation may be avoidable.
    Murphy WG; Ghosh S; Hughes RH; Craig JI; Greer IA
    BMJ; 1994 Sep; 309(6957):806. PubMed ID: 7848430
    [No Abstract]   [Full Text] [Related]  

  • 6. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin?
    Hannafin B; Lovecchio F; Blackburn P
    Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpreting a post-partum Kleihauer test.
    Bain BJ; Chapple L
    Am J Hematol; 2015 Jan; 90(1):77. PubMed ID: 25379835
    [No Abstract]   [Full Text] [Related]  

  • 8. Fetal-Maternal Hemorrhage Detected by Sudden Disappearance of Rh Immune Globulin-Related Anti-D.
    King JR; Zeger GD; Plaza N; Lee RH; Shulman IA
    Obstet Gynecol; 2015 Dec; 126(6):1301-1302. PubMed ID: 26375716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].
    Mannessier L; Alie-Daram S; Roubinet F; Valat AS; Depoortère MH; Fournié A; Puech F
    J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):441-4. PubMed ID: 11011272
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinically silent massive fetomaternal hemorrhage: important lessons from an illustrative case.
    Post GR; Lazarchick J; Singh ZN
    Lab Hematol; 2012 Jun; 18(2):11-3. PubMed ID: 22709788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal-maternal bleed in the second trimester of pregnancy. A report of two cases.
    Gass ML; Carey PM
    J Reprod Med; 1992 Apr; 37(4):378-80. PubMed ID: 1317453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion medicine illustrated. Miscounting even one lymphocyte in the Kleihauer-Betke (acid-elution) assay can result in overdosing Rh immune globulin.
    Shen R; Sandler SG
    Transfusion; 2015 Sep; 55(9):2069. PubMed ID: 25683487
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ante-partum administration of preventive treatment of Rh-D immunization in rhesus-negative women. Parallel evaluation of transplacental passage of fetal blood cells. Results of a multicenter study carried out in the Paris region].
    Huchet J; Dallemagne S; Huchet C; Brossard Y; Larsen M; Parnet-Mathieu F
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):101-11. PubMed ID: 3035003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of massive transplacental haemorrhage by flow cytometry.
    Fong EA; Davies JI; Grey DE; Reid PJ; Erber WN
    Clin Lab Haematol; 2000 Dec; 22(6):325-7. PubMed ID: 11318797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of Rh immunization. II. Management of the risk during the second half of pregnancy and postpartum].
    Larsen JF; Bock JE; Jørgensen JR
    Ugeskr Laeger; 2004 Aug; 166(36):3078-83. PubMed ID: 15387304
    [No Abstract]   [Full Text] [Related]  

  • 16. Kleihauer testing. Immunofluorescence microsphere test developed.
    Van Dijk BA; De Man CJ; Kunst VA
    BMJ; 1994 Sep; 309(6957):805-6. PubMed ID: 7950583
    [No Abstract]   [Full Text] [Related]  

  • 17. Inaccurate doses of Rh immune globulin after Rh-incompatible fetomaternal hemorrhage-survey of laboratory practice.
    Lafferty J; Raby A; Keeney M; Flynn GJ; Crowther M
    Arch Pathol Lab Med; 2009 Dec; 133(12):1910-1. PubMed ID: 19961242
    [No Abstract]   [Full Text] [Related]  

  • 18. Anti-D guidelines.
    Kanjilal K; Tasker M
    Br J Fam Plann; 2000 Oct; 26(4):244. PubMed ID: 11053891
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antenatal anti-Rh(D) antigen prophylaxis].
    Katsulov A;
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():3-7. PubMed ID: 11785354
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evaluation of fetomaternal hemorrhage in postpartum patients with indication for administration of anti-D immunoglobulin].
    Baiochi E; Camano L; Bordin JO
    Cad Saude Publica; 2005; 21(5):1357-65. PubMed ID: 16158140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.